Search Results
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
Search for other papers by Massimo Terzolo in
Google Scholar
PubMed
Search for other papers by Paola Sperone in
Google Scholar
PubMed
Search for other papers by Anna Pia in
Google Scholar
PubMed
Search for other papers by Silvia Della Casa in
Google Scholar
PubMed
Search for other papers by David J Gross in
Google Scholar
PubMed
Search for other papers by Carlo Carnaghi in
Google Scholar
PubMed
Search for other papers by Paolo Casali in
Google Scholar
PubMed
Search for other papers by Francesco Porpiglia in
Google Scholar
PubMed
Search for other papers by Franco Mantero in
Google Scholar
PubMed
Search for other papers by Giuseppe Reimondo in
Google Scholar
PubMed
Search for other papers by Alberto Angeli in
Google Scholar
PubMed
Search for other papers by Luigi Dogliotti in
Google Scholar
PubMed
Introduction Adrenocortical carcinoma (ACC) is an extremely rare disease with an annual incidence ranging between 0.5 and 2 cases per million population ( Crucitti et al. 1996 , Icard et al. 2001 ) in western countries. ACC
Search for other papers by Daniele Generali in
Google Scholar
PubMed
Search for other papers by Stephen B Fox in
Google Scholar
PubMed
Search for other papers by Alfredo Berruti in
Google Scholar
PubMed
Search for other papers by Maria P Brizzi in
Google Scholar
PubMed
Search for other papers by Leticia Campo in
Google Scholar
PubMed
Search for other papers by Simone Bonardi in
Google Scholar
PubMed
Search for other papers by Simon M Wigfield in
Google Scholar
PubMed
Search for other papers by Paolo Bruzzi in
Google Scholar
PubMed
Search for other papers by Alessandra Bersiga in
Google Scholar
PubMed
Search for other papers by Giovanni Allevi in
Google Scholar
PubMed
Search for other papers by Manuela Milani in
Google Scholar
PubMed
Search for other papers by Sergio Aguggini in
Google Scholar
PubMed
Search for other papers by Luigi Dogliotti in
Google Scholar
PubMed
Search for other papers by Alberto Bottini in
Google Scholar
PubMed
Search for other papers by Adrian L Harris in
Google Scholar
PubMed
representative regions of each paraffin-embedded breast tumor and sections of 5 μm thickness of each tissue array block were transferred to the glass slides. Quality control was assessed on each block by haepatoxylin and eosin (H&E) staining
Search for other papers by Xianhui Ruan in
Google Scholar
PubMed
Search for other papers by Xianle Shi in
Google Scholar
PubMed
Search for other papers by Qiman Dong in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Xiukun Hou in
Google Scholar
PubMed
Search for other papers by Xinhao Song in
Google Scholar
PubMed
Search for other papers by Xi Wei in
Google Scholar
PubMed
Search for other papers by Lingyi Chen in
Google Scholar
PubMed
Search for other papers by Ming Gao in
Google Scholar
PubMed
, dehydrated through xylenes and alcohols, and embedded in paraffin. Sections were cut at 5 μm and stained with haematoxylin and eosin (HE) for histological examination. Immunohistochemistry was performed according to standard protocols. Signal was visualized
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Carolina Di Somma in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Gaetano Lombardi in
Google Scholar
PubMed
Search for other papers by Silvia Savastano in
Google Scholar
PubMed
(96.5%) and the main presenting symptoms are visual defects (67.8%) and headache (41.4%), and the most frequent pituitary deficit was hypogonadism (43.3%). Neurosurgery is the treatment of choice of these tumours ( Jaffe 2006 ). However, because of
Search for other papers by Lidong Wang in
Google Scholar
PubMed
Search for other papers by Hao Tan in
Google Scholar
PubMed
Search for other papers by Yonglian Huang in
Google Scholar
PubMed
Search for other papers by Mingyue Guo in
Google Scholar
PubMed
Search for other papers by Yanxu Dong in
Google Scholar
PubMed
Search for other papers by Chenxi Liu in
Google Scholar
PubMed
Search for other papers by Huai Zhao in
Google Scholar
PubMed
Search for other papers by Zhen Liu in
Google Scholar
PubMed
Introduction Papillary thyroid carcinoma (PTC), as the most frequent histological subtype, accounts for more than 85% of thyroid cancers ( Canberk et al. 2020 ). The incidence of PTC has markedly increased over the past decades ( He et al
Barts and the London School of Medicine, Department of Endocrinology and Internal Medicine, Centre for Endocrinology, London EC1M 6BQ, UK
Search for other papers by Dorota Dworakowska in
Google Scholar
PubMed
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
DNA ( van Slegtenhorst et al . 1997 ). The TSC2 gene, which is located on chromosome 16p13, encodes a transcript of 5.5 kb, containing 41 exons and encompassing 40 kb genomic DNA ( Xu et al . 1995 ; Fig. 1 ). TSC1 and TSC2 genes encode
Departments of, Pharmacology, Urology and NYU Cancer Institute, Psychiatry, Department of Nephrology, New York University School of Medicine, 550 First Avenue, MSB424, New York, New York 10016, USA
Search for other papers by Susan Ha in
Google Scholar
PubMed
Departments of, Pharmacology, Urology and NYU Cancer Institute, Psychiatry, Department of Nephrology, New York University School of Medicine, 550 First Avenue, MSB424, New York, New York 10016, USA
Search for other papers by Rachel Ruoff in
Google Scholar
PubMed
Departments of, Pharmacology, Urology and NYU Cancer Institute, Psychiatry, Department of Nephrology, New York University School of Medicine, 550 First Avenue, MSB424, New York, New York 10016, USA
Search for other papers by Nicole Kahoud in
Google Scholar
PubMed
Departments of, Pharmacology, Urology and NYU Cancer Institute, Psychiatry, Department of Nephrology, New York University School of Medicine, 550 First Avenue, MSB424, New York, New York 10016, USA
Search for other papers by Thomas F Franke in
Google Scholar
PubMed
Departments of, Pharmacology, Urology and NYU Cancer Institute, Psychiatry, Department of Nephrology, New York University School of Medicine, 550 First Avenue, MSB424, New York, New York 10016, USA
Search for other papers by Susan K Logan in
Google Scholar
PubMed
prostate of the transgenic animals relative to WT mice. Comparable levels of keratin 14 ( Fig. 4 A) suggest that there was no loss of basal epithelial cells, consistent with the lack of a tumorigenic phenotype in the myr-Akt1 animals. Figure 5 H&E staining
Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Search for other papers by Ali S Alzahrani in
Google Scholar
PubMed
Search for other papers by Meshael Alswailem in
Google Scholar
PubMed
Département de Médecine Génomique des Tumeurs et des Cancers, Fédération de Génétique et de Médecine Génomique, Assistance Publique-Hôpitaux de Paris (AP-HP) Centre, Hôpital Européen Georges Pompidou, Paris, France
Search for other papers by Alexandre Buffet in
Google Scholar
PubMed
Search for other papers by Balgees Alghamdi in
Google Scholar
PubMed
Search for other papers by Lulu Alobaid in
Google Scholar
PubMed
Search for other papers by Osamah Alsagheir in
Google Scholar
PubMed
Search for other papers by Hindi Al-Hindi in
Google Scholar
PubMed
Search for other papers by Karel Pacak in
Google Scholar
PubMed
) did not reveal any pathogenic variant. The primers and PCR conditions were described previously ( Albattal et al. 2019 ). Subsequently, an EPAS1 variant (NM_001430.5: c.1592C>A, p.Pro531His) was found by next-generation sequencing (NGS) of tumor
Search for other papers by Eva S Schernhammer in
Google Scholar
PubMed
Search for other papers by Shelley S Tworoger in
Google Scholar
PubMed
Search for other papers by A Heather Eliassen in
Google Scholar
PubMed
Search for other papers by Stacey A Missmer in
Google Scholar
PubMed
Search for other papers by Jeff M Holly in
Google Scholar
PubMed
Search for other papers by Michael N Pollak in
Google Scholar
PubMed
Search for other papers by Susan E Hankinson in
Google Scholar
PubMed
examined the cross-sectional associations of birth weight, body shape at ages 5 and 10, BMI at age 18 and adulthood, bra cup size at age 20, adult waist circumference and waist-to-hip ratio (WHR), as well as attained height in relation to IGF-I, IGFBP-3
Search for other papers by James C Yao in
Google Scholar
PubMed
Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Search for other papers by Emily Bergsland in
Google Scholar
PubMed
Search for other papers by Philippe Ruszniewski in
Google Scholar
PubMed
Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Search for other papers by Daneng Li in
Google Scholar
PubMed
Search for other papers by Salvatore Tafuto in
Google Scholar
PubMed
Search for other papers by Nitya Raj in
Google Scholar
PubMed
Search for other papers by Davide Campana in
Google Scholar
PubMed
Search for other papers by Susumu Hijioka in
Google Scholar
PubMed
Search for other papers by Markus Raderer in
Google Scholar
PubMed
Search for other papers by Rosine Guimbaud in
Google Scholar
PubMed
Search for other papers by Pablo Gajate in
Google Scholar
PubMed
Search for other papers by Sara Pusceddu in
Google Scholar
PubMed
Search for other papers by Albert Reising in
Google Scholar
PubMed
Search for other papers by Evgeny Degtyarev in
Google Scholar
PubMed
Search for other papers by Mark Shilkrut in
Google Scholar
PubMed
Search for other papers by Simantini Eddy in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
every 30 days up to 150 days following the last dose, or until the start of subsequent antineoplastic medication between 30 and 150 days after the last dose. The European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and EQ-5D-5L